Generics for Otezla® to be out in the United States in February 2028
Tanu Goyal
September 14, 2023
Generics for Otezla® to be out in the United States in February 2028 Amgen’s oral phosphodiesterase-4 (PDE-4) inhibitor – Otezla® (Apremilast) is approved in the